Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
51.9M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
7.53M
-
Shares change
-
-648K
-
Total reported value, excl. options
-
$21.2M
-
Value change
-
-$2.45M
-
Number of buys
-
14
-
Number of sells
-
-16
-
Price
-
$2.82
Significant Holders of ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO) as of Q1 2023
43 filings reported holding ABEO - ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value as of Q1 2023.
ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.53M shares
of 51.9M outstanding shares and own 14.5% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (1.43M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.33M shares), Point72 Asset Management, L.P. (1.15M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (870K shares), AIGH Capital Management LLC (652K shares), VANGUARD GROUP INC (458K shares), Western Standard LLC (224K shares), BARCLAYS PLC (186K shares), GEODE CAPITAL MANAGEMENT, LLC (182K shares), and MILLENNIUM MANAGEMENT LLC (178K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.